Combinig diabetes drug and immunotherapy against breast cancer

01:00 EST 11 Feb 2019 | Bionity

image description
MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer cells to build more macromolecules (anabolic metabolism) it also creates a metabolic vulnerability by making them more sensitive to a type of cell death known as apopto...

Original Article: Combinig diabetes drug and immunotherapy against breast cancer

More From BioPortfolio on "Combinig diabetes drug and immunotherapy against breast cancer"